AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AbbVie Inc. Director's Dealing 2019

Aug 16, 2019

29755_dirs_2019-08-16_d50b74ec-f979-4a9c-a5ff-2b99d34504d9.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2019-08-14

Reporting Person: Gosebruch Henry O (EVP, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-14	Common Stock, $0.01 par value	G	30000	—	Disposed	45763	Direct
2019-08-14	Common Stock, $0.01 par value	G	30000	—	Acquired	30000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	2276	Indirect

Footnotes

F1: The reporting person is trustee of a trust established for the benefit of his children. The reporting person disclaims beneficial ownership of all securities held by the trust.

F2: Balance in AbbVie Savings program as of July 30, 2019.